CLASS II Device recall · Reported 2 Dec 2015 · FDA Enforcement Report

Bd Cd64 Apc-r700 recalled by Becton, Dickinson and

Becton, Dickinson and Company, BD Biosciences is recalling Bd Cd64 Apc-r700, distributed in 9 states. The recall was initiated on 30 Oct 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel 657701; Lot No. 4344945, 5037611, both with expiry date of 31 DEC 2015; and 5063945 with expiry dte of 29 FEB 2016.
Quantity recalled23 vials

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0334-2016
FDA event ID
72548
Classification
Class II
Status
Terminated
Recall initiated
30 Oct 2015
FDA classified
24 Nov 2015
Reported
2 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Oct 2015Recall initiated by company
24 Nov 2015Classified by FDA+25 days
2 Dec 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Three lots of CD64 (MD22) are contaminated with CD4 antibody.

Product as listed by the FDA

BD CD64 APC-R700; Analyte Specific Reagent; Model 657701; Lot No. 4344945, 5037611 and 5063945. Hematology - used as analyte specific reagent - contamination leads to possibility of unexpected staining pattern.

Where it was distributed

Distributed in the states of FL, WA, PA, IL, GA, RI, TX, ND, and IA.

FloridaGeorgiaIowaIllinoisNorth DakotaPennsylvaniaRhode IslandTexasWashington

Questions about this recall

Why was it recalled?

Three lots of CD64 (MD22) are contaminated with CD4 antibody.

Which lots are affected?

Model 657701; Lot No. 4344945, 5037611, both with expiry date of 31 DEC 2015; and 5063945 with expiry dte of 29 FEB 2016.

Where was it sold?

Distributed in the states of FL, WA, PA, IL, GA, RI, TX, ND, and IA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Becton, Dickinson and Company, BD Biosciences

All 35

Other Test Kits & Diagnostics recalls

All 2,656